Log in or Sign up for Free to view tailored content for your specialty!
Liver/Biliary Disorders News

Biomarkers identified by machine learning could assist in diagnosing liver diseases
Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis, researchers reported.
‘No beneficial effects’ from simvastatin plus rifaximin for decompensated cirrhosis

The addition of simvastatin plus rifaximin to standard therapy did not improve outcomes among patients with decompensated cirrhosis who were at high risk for clinical complications, according to a study published in JAMA.
Study: Live vaccines safe, effective in pediatric transplant recipients

Most pediatric transplant recipients who received live-attenuated viral vaccines after transplant developed protective antibodies that persisted for up to a year after vaccination with no significant safety events, researchers found.
Log in or Sign up for Free to view tailored content for your specialty!
Normothermic machine perfusion boosts liver transplant outcomes, may expand donor criteria

Normothermic machine perfusion was linked to significant improvements in liver transplant clinical outcomes and reduced hospital resource use, especially among patients who received donation after circulatory death allografts, data show.
Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial

The AHFIRM trial did not demonstrate a beneficial effect of larsucosterol on 90-day mortality or the need for liver transplant among patients with severe alcohol-associated hepatitis, or AH, according to a study published in NEJM Evidence.
Q&A: ‘Unacceptable’ medical deserts leave rural patients with rare diseases stranded

Approximately 14% of the U.S. population lives in rural areas, where access to health care may be limited by insurance coverage, geography and infrastructure, and provider shortages, according to HHS.
HCV testing guidelines tied to increased screening for pregnant women

Despite decreased population-level hepatitis C virus screening in 2020, guidance to test all adults and during every pregnancy was associated with increased HCV screening for pregnant women, according to a research letter published in JAMA.
Metabolic surgery slashed risk for adverse outcomes in MASH-related cirrhosis, obesity

Metabolic surgery significantly lowered risk for major adverse liver outcomes vs. nonsurgical management among patients with obesity and compensated cirrhosis from metabolic dysfunction-associated steatohepatitis, according to study data.
FMT safe, linked to reduced hepatic encephalopathy recurrence in patients with cirrhosis

Fecal microbiota transplant, regardless of dose or route, was safe and associated with reduced hepatic encephalopathy recurrence among patients with cirrhosis receiving lactulose and rifaximin, according to a study in Journal of Hepatology.
Injectable naltrexone tops disulfiram, acamprosate as safer option in alcohol use disorder

Injectable naltrexone had a more favorable gastrointestinal and liver safety profile compared with other medications for alcohol use disorder, according to a research letter published in Clinical Gastroenterology and Hepatology.
-
Headline News
Cancer surgeon runs the globe to raise testicular cancer awareness
March 21, 20258 min read -
Headline News
FDA launches online database for chemical containment levels in food
March 20, 20251 min read -
Headline News
‘Early events’ can increase a person’s risk for long COVID
March 20, 20253 min read
-
Headline News
Cancer surgeon runs the globe to raise testicular cancer awareness
March 21, 20258 min read -
Headline News
FDA launches online database for chemical containment levels in food
March 20, 20251 min read -
Headline News
‘Early events’ can increase a person’s risk for long COVID
March 20, 20253 min read